Chromatography sales reached nearly $8.5 billion in 2016, having rebounded from weak growth due to currency effects in the previous year. In 2017, moderate sales increases are expected to continue. We project this market segment will be fueled by the rise of clinical chromatography, as well as increased regulations in the pharmaceutical and food industries, […]
In our 2017 IBO Review & Forecast issue, we report that instrument and laboratory product companies, just like other industries, felt the effects of 2016’s high degree of uncertainty. Political developments, such as Brexit and the US election, as well as economic questions, including growth expectations for China and the possibility of higher US interest […]
The Instrument Business Outlook “Company of the Year” Award honors a company that has demonstrated outstanding technical, operational and financial achievements during the year. IBO’s 12th annual “Company of the Year” Award goes to Bio-Techne. In 2016, life science research and biopharma drug development were key markets for technical innovation, sales demand and customer engagement. Bio-Techne capitalized […]
